Antibiotic prophylaxis with cefazolin and gentamicin in cardiac surgery for children less than ten kilograms

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 17, Issue 2, 2003, Pages 221-225

  Haessler, Denis ^b   Reverdy, Marie Elisabeth ^b   Neidecker, Jean ^b   Brûlé, Pierre ^b   Ninet, Jean ^b   Lehot, Jean Jacques ^a  

^a LOUIS PRADEL HOSPITAL   (France)

^b NONE

Author keywords

Antibiotic prophylaxis; Cardiac surgery; Cefazolin; Congenital cardiac disease; Gentamicin

Indexed keywords

ANTIBIOTIC AGENT; CEFAZOLIN; GENTAMICIN;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; BLOOD SAMPLING; BODY WEIGHT; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG EFFICACY; FEMALE; FLUORESCENCE; HEART SURGERY; HUMAN; IMMUNOASSAY; INFANT; INTENSIVE CARE UNIT; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; UNIVERSITY HOSPITAL;

EID: 0344921408     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/jcan.2003.51     Document Type: Article

References (31)

1. Amaker RD, DiPiro JT, Bhatia J: Pharmacokinetics of vancomycin in critically ill infants undergoing extracorporeal membrane oxygenation. Antimicrob Agents Chemother 40:1139-1142. 1996
2. Lee KR, Ring JC, Leggiadro R: Prophylactic antibiotic use in pediatric cardiovascular surgery: A survey of current practice. Pediatr Infect Dis J 14:267-269, 1995
3. Kiss J, Farago E, Gomory A, et al: Gentamycin in cardiac surgery. Acta Chir Acad Sci Hung 18:133-139, 1977
4. Lehot JJ, Reverdy ME, Etienne J, et al: Cefazolin and netilmicin levels during and after cardiac surgery with cardiopulmonary-bypass. J Cardiothorac Anesth 4:204-209, 1990
5. Jolley ME, Stroupe SD, Wang CH, et al: Fluorescence polarization immunoassay. I. Monitoring aminoglycoside antibiotics in serum and plasma. Clin Chem 27:1190-1197, 1981
6. Schumitzky A: Nonparametic EM algorithms for estimating prior distribution. Appl Math Comput 45:143-157, 1991
7. Lehot JJ, Reverdy ME, Etienne J, et al: Oxacillin and tobramycin serum levels during cardiopulmonary bypass. J Cardiothoracic Anesth 3:163-167, 1989
8. Capparelli EV, Lane JR, Romanowski GL, et al: The influences of renal function and maturation on vancomycin elimination in newborns and infants. J Clin Pharmacol 41:927-934, 2001
9. O'Rullian JJ, Wise RK, McCoach RM, et al: The effects of haemofiltration on cefazolin levels during cardiopulmonary bypass. Perfusion 13:176-180, 1998
10. Williams BS, Ransom JL, Gal P, et al: Gentamicin pharmacokinetics in neonates with patent ductus arteriosus. Crit Care Med 25:273-275, 1997
11. Classen DC, Evans RS, Pestotnik SL, et al: The timing of prophylactic administration of antibiotics and the risk of surgical wound infection. N Engl J Med 326:281-286, 1992
12. Matuschka PR, Cheadle WG, Burke JD, et al: A new standard of care: Administration of preoperative antibiotics in the operative room. Am Surg 63:500-503, 1997
13. NCCLS (Approved Standard). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically (ed 4). 1997, document M704, vol 17,2
14. Vogelman B, Gudmundsson S, Leggett J, et al: Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model. J Infect Dis 158:831-847, 1988
15. Dahlgren JG, Anderson ET, Hewitt WL: Gentamicin blood levels: A guide to nephrotoxicity. Antimicrob Agents Chemother 8:58-62, 1975
16. Verpooten GA, Giuliano RA, Verbist L, et al: Once-daily dosing decreases renal accumulation of gentamicin and netilmicin. Clin Pharmacol Ther 45:22-27, 1989
17. Postovsky S, Ben Arush MW, Kassis E, et al: Pharmacokinetic analysis of gentamicin thrice and single daily dosage in pediatric cancer patients. Pediatr Hematol Oncol 14:547-554, 1997
18. Moore RD, Lietman PS. Smith CR: Clinical response to aminoglycoside therapy: Importance of the ratio of peak concentration to minimal inhibitory concentration. J Infect Dis 155:93-99, 1987
19. Lewis DR, Longman RJ, Wisheart JD, et al: The pharmacokinetics of a single dose of gentamicin (4 mg/kg) as prophylaxis in cardiac surgery requiring cardiopulmonary bypass. Cardiovasc Surg 7:398-401, 1999
20. Giacoia GP, Schentag JJ: Pharmacokinetics and nephrotoxicity of continuous intravenous infusion of gentamicin in low-birth-weight infants. J Pediatr 109:715-719, 1986
21. Mercieri M, Merciery A, Tritapepe L, et al: High-dose aprotinin with gentamicin-vancomycin antibiotic prophylaxis increases blood concentrations of creatinine and and cystatin C in patients undergoing coronary artery bypass grafting. Br J Anaesth 82:531-536, 1999
22. Heylen RM, Wilson AP, Hichens M, et al: Antibiotic prophylaxis in cardiac surgery: Factors associated with potentially toxic serum concentrations of gentamicin. J Antimicrob Chemother 35:657-667. 1995
23. Davies MW, Cartwright DW: Gentamicin dosage intervals in neonates: Longer dosage interval-less toxicity. J Paediatr Child Health 34:577-580, 1996
24. Osturk HS, Kavutcu M, Kacmaz M, et al: The effects of gentamicin on the activities of glutathione peroxidase and superoxide dismutase enzymes and malondialehyde levels in heart tissues of guinea pigs. Curr Med Res Opin 14:47-52, 1997
25. Kaiser AB, Petracek MR, Lea JW 4th, et al: Efficacy of cefazolin, cefamandole and gentamicin as prophylactic agents in cardiac surgery. Results of a prospective, randomized, double-blind trial in 1,030 patients. Ann Surg 206:791-797, 1987
26. Colson P, Ribstein J, Mimran A, et al: Effects of angiotensin converting enzyme inhibition on blood pressure and renal function during open heart surgery. Anesthesiology 72:23-27, 1990
27. Mazzarella V, Galluci MT, Tozzo C, et al: Renal function in patients undergoing cardiopulmonary bypass operations. J Thorac Cardiovasc Surg 104:1625-1627, 1992
28. Bucknell SJ, Mohajeri M, Low J, et al: Single-versus multiple-dose antibiotics prophylaxis for cardiac surgery. Aust N Z J Surg 70:409-411, 2000
29. Vuorisalo S, Pokela R, Syrjala H: Is single-dose antibiotic prophylaxis sufficient for coronary artery bypass surgery? An analysis of peri- and postoperative serum cefuroxime and vancomycin levels. J Hosp Infect 37:237-247, 1997
30. Henley CM, Rybak LP: Developmental ototoxicity. Otolaryngol Clin North Am 26:857-871, 1993
31. Matz GJ: Aminoglycoside cochlear ototoxicity. Otolaryngol Clin North Am 26:705-712. 1993